Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts John Davis brings direct clinical expertise as...

Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer Key appointment bringing 30 years of drug discovery and development expertise as the Company continues to build a...

Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board Dr Greig brings more than 40 years of experience in the biopharmaceutical sectorExperienced Chair who has led...

Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature New method is being used by Nucleome to unlock the...